Adaptive Biotechnologies Corp
(HAM:1HM)
€
18.54
-1.295 (-6.53%)
Market Cap: 2.98 Bil
Enterprise Value: 2.86 Bil
PE Ratio: 0
PB Ratio: 15.63
GF Score: 47/100 Adaptive Biotechnologies Corp at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022 / 02:50PM GMT
Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Research Analyst
Good morning. Welcome to Day 3 of the Cowen Healthcare Conference. I'm Dan Brennan, one of the tools and diagnostics analyst here. Really pleased to be joined with me on the virtual stage here, Chad Robins, Co-Founder, CEO, Chairman of Adaptive Bio. I have known Chad for a while. So first off, just, Chad, welcome and thanks for being here.
Chad M. Robins
Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman
Hey Dan, thanks for having me. It's great to be back at Cowen.
Questions & Answers
Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Research Analyst
Awesome. So I'd like to kick it off just with the news out today a couple of announcements. So first, Tycho Peterson, the new CFO. Secondly, you announced the reorientation of the business under MRD and immune medicine, which have been discussed and then also a workforce reduction. So first, on Tycho, that's awesome. He's going to be
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot